XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
OPERATING ACTIVITIES      
Net Loss/Gain $ (1,680,723) $ (545,709)  
Adjustments to Reconcile Net Loss to Net Cash Flow from Operating Activities:      
Bad Debt 10,651 $ 248,413
Shares issued for compensation   33,336  
Distribution to affiliate (1,683,865) (1,019,687)  
Impairment    
Depreciation & Amortization 237,011 185,316  
Net Change, Right-of-Use Asset & Liabilities 20,059  
Change in Operating Assets & Liabilities:      
Accounts Receivable 58,800 373,055  
Contract Assets 120,550  
Inventory 322,167 110,816  
Prepaids & Other Current Assets (213,247) (75,565)  
Accounts Payable 732,922 83,261  
Contract Liabilities 295,873    
Accrued Expenses 207,475 (82,531)  
Deferred Revenue 415,107 71,452  
Net Cash Used in Operating Activities (1,157,220) (866,256)  
INVESTING ACTIVITIES      
Purchase of Property, Plant an Equipment (22,560) (161,755)  
Net Cash Used in Investing Activities (22,560) (161,755)  
FINANCING ACTIVITIES      
Borrowings on debt 825,000  
Net Cash provided by (used in) Financing Activities 825,000  
Net Cash Flow for Period (354,780) (1,028,011)  
Cash and Cassh Equivalents - Beginning of Period 533,871 6,201,137 6,201,137
Cash and Cash Equivalents- End of Period 179,091 5,173,126 $ 533,871
NON-CASH INVESTING AND FINANCING ACTIVITIES      
Shares issued for Investment 100,000  
Transfer demo inventory to PPE $ 14,833  
SUPPLEMENTARY CASH FLOW INFORMATION      
Cash Received / Paid During the Period for:    
Income Taxes  
Interest